AR075208A1 - DERIVATIVES OF 4-AMINO-7,8-DIHIDROPIRIDO [4,3-D] PIRIMIDIN-5 (6H) -ONA, PHARMACEUTICAL COMPOSITIONS THAT UNDERSTAND AND USE THE SAME IN THE TREATMENT OF OBESITY AND / OR DIABETES. - Google Patents

DERIVATIVES OF 4-AMINO-7,8-DIHIDROPIRIDO [4,3-D] PIRIMIDIN-5 (6H) -ONA, PHARMACEUTICAL COMPOSITIONS THAT UNDERSTAND AND USE THE SAME IN THE TREATMENT OF OBESITY AND / OR DIABETES.

Info

Publication number
AR075208A1
AR075208A1 ARP100100265A ARP100100265A AR075208A1 AR 075208 A1 AR075208 A1 AR 075208A1 AR P100100265 A ARP100100265 A AR P100100265A AR P100100265 A ARP100100265 A AR P100100265A AR 075208 A1 AR075208 A1 AR 075208A1
Authority
AR
Argentina
Prior art keywords
dihidropirido
pirimidin
ona
obesity
diabetes
Prior art date
Application number
ARP100100265A
Other languages
Spanish (es)
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of AR075208A1 publication Critical patent/AR075208A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Reivindicacion 1: Un compuesto que tiene la formula (1) en la que R1 es H, alcoxi C1-2, alquilo C1-2 halosustituido, alcoxi C1-2 halosustituido o alquilo C1-2; cada R2 es independientemente halogeno, OH, alquilo C1-4, ciano, cicloalquilo C3-6 o alcoxi C1-4; R3 es H, alquilo C1-2, alcoxi C1-2, o -O-alquilo C1-2-alcoxi C1-2; y m es 0, 1, 2, o 3; o una sal farmacéuticamente aceptable del mismo.Claim 1: A compound having the formula (1) wherein R1 is H, C1-2 alkoxy, halosubstituted C1-2 alkyl, halosubstituted C1-2 alkoxy or C1-2 alkyl; each R2 is independently halogen, OH, C1-4 alkyl, cyano, C3-6 cycloalkyl or C1-4 alkoxy; R3 is H, C1-2 alkyl, C1-2 alkoxy, or -O-C1-2 alkyl-C1-2 alkoxy; and m is 0, 1, 2, or 3; or a pharmaceutically acceptable salt thereof.

ARP100100265A 2009-02-03 2010-02-01 DERIVATIVES OF 4-AMINO-7,8-DIHIDROPIRIDO [4,3-D] PIRIMIDIN-5 (6H) -ONA, PHARMACEUTICAL COMPOSITIONS THAT UNDERSTAND AND USE THE SAME IN THE TREATMENT OF OBESITY AND / OR DIABETES. AR075208A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14952209P 2009-02-03 2009-02-03
US28525809P 2009-12-10 2009-12-10

Publications (1)

Publication Number Publication Date
AR075208A1 true AR075208A1 (en) 2011-03-16

Family

ID=42060744

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP100100265A AR075208A1 (en) 2009-02-03 2010-02-01 DERIVATIVES OF 4-AMINO-7,8-DIHIDROPIRIDO [4,3-D] PIRIMIDIN-5 (6H) -ONA, PHARMACEUTICAL COMPOSITIONS THAT UNDERSTAND AND USE THE SAME IN THE TREATMENT OF OBESITY AND / OR DIABETES.

Country Status (4)

Country Link
AR (1) AR075208A1 (en)
TW (1) TW201040174A (en)
UY (1) UY32412A (en)
WO (1) WO2010089685A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6099753B2 (en) * 2012-10-03 2017-03-22 アドビナス セラピューティクス リミテッド Spirocyclic compound, composition thereof and pharmaceutical application thereof
CN111018833B (en) * 2019-12-13 2021-01-01 宁波申泰生物科技有限公司 Apixaban intermediate and preparation method thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6100077A (en) 1998-10-01 2000-08-08 The Trustees Of Columbia University In The City Of New York Isolation of a gene encoding diacylglycerol acyltransferase
EP1383501B1 (en) 2001-02-28 2007-04-04 Merck & Co., Inc. Acylated piperidine derivatives as melanocortin-4 receptor agonists
EP1562956A4 (en) 2002-11-22 2007-10-10 Japan Tobacco Inc Fused bicyclic nitrogen-containing heterocycles
WO2005017187A2 (en) 2003-08-04 2005-02-24 Bayer Pharmaceuticals Corporation Methods for screening and identifying compounds
AU2005209115A1 (en) * 2004-01-30 2005-08-11 Japan Tobacco Inc. Anorectic compounds
AP2006003768A0 (en) 2004-05-25 2006-10-31 Pfizer Prod Inc TetraazabenzoÄeÜazulene derivatives and analogs tehereof
PA8660701A1 (en) 2005-02-04 2006-09-22 Pfizer Prod Inc SMALL AGONISTS AND THEIR USES
US20090036425A1 (en) * 2007-08-02 2009-02-05 Pfizer Inc Substituted bicyclolactam compounds

Also Published As

Publication number Publication date
WO2010089685A1 (en) 2010-08-12
UY32412A (en) 2010-09-30
TW201040174A (en) 2010-11-16

Similar Documents

Publication Publication Date Title
AR081058A1 (en) DERIVATIVES OF ARILMETOXI ISOINDOLINA, COMPOSITIONS THAT INCLUDE THEM AND THEIR USE IN THE TREATMENT OF CANCER.
SV2009003281A (en) ESPIRO KETONA ACETIL-COA CARBOXILASA.0 INHIBITORS.
CR20150085A (en) NEW 6-AMINO ACID-HETEROARILDIHYDROPIRMIDINDAS FOR THE TREATMENT AND PROFILAXIS OF HEPATITIS B VIRUS INFECTION
AR076171A1 (en) PIRAZOLOPIRIMIDINONES 1.6-DISUSTITUIDAS, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AND USE OF THE SAME FOR THE TREATMENT OF ALZHEIMER, EPILEPSY AND OTHER DISEASES OF THE CENTRAL NERVOUS SYSTEM.
AR072261A1 (en) PIPERAZIN-PIRAZOLIC DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEMSELVES AND USES OF THE SAME AS ANTICANCERIGEN AGENTS.
AR064561A1 (en) DERIVATIVES OF 2-AZA-BICYCLE [3.1.0] HEXANE AND ITS USE IN THE PREPARATION OF A MEDICINAL PRODUCT FOR THE TREATMENT OF DISEASES RELATED TO GENERAL DYSFUNCTIONS OF THE OREXINE SYSTEM.
DOP2012000310A (en) MORPHOLINOPIRIMIDINAS AND ITS USE IN THERAPY
BR112012023382A2 (en) imidazopyridine compounds, compositions and methods of use.
UY30819A1 (en) DERIVATIVES OF PIRAZOL, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, PREPARATION PROCESSES AND APPLICATIONS
AR088622A1 (en) 18-METHYL-6,7-METHYLENE-3-OXO-17-PREGN-4-EN-21,17b-CARBOLACTONE, PHARMACEUTICAL PREPARATIONS CONTAINING THE MENTIONED COMPOUNDS AND THEIR USE IN THE THERAPY OF ENDOMETRIOSIS
ATE519764T1 (en) SPIROINDOLINONE DERIVATIVES
EA201200049A1 (en) 1,3-DESIGNED DERIVATIVES OF IMIDAZOLIDIN-2-IT AS CYP 17 INHIBITORS
UY29886A1 (en) NEW PIRAZOL DERIVATIVES, PHARMACCUTIC COMPOSITIONS CONTAINING THEM, PROCEDURES FOR THE PREPARATION OF THE SAME AND APPLICATIONS
AR077629A1 (en) SMAC MIMETICO
CO6230986A2 (en) COMPOSITE OF 4-PYRIDINONE AND ITS USE FOR CANCER
CL2008002049A1 (en) Macrocyclic aminoindole derived compounds; pharmaceutical composition comprising said compound; and use of the compound for the treatment of hepatitis c.
AR071120A1 (en) DERIVATIVES OF DIOSMETINE, ITS PREPARATION PROCEDURE, THE PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AND THEIR USE IN THE TREATMENT OF CHRONIC VENOUS DISEASES.
SV2009003389A (en) PIRIDO COMPOUNDS [2,3-D] PIRIMIDINA-7-ONA AS P13K-ALFA INHIBITORS FOR CANCER TREATMENT
WO2009092278A8 (en) Thienopyridazine compounds, their preparations, pharmaceutical compositions and uses
AR087470A1 (en) BIFENILENIC IMIDAZOLIC DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
ES2531159T3 (en) Compounds and methods for cancer treatment
PH12015501386A1 (en) Tricyclic compounds
UY29739A1 (en) DERIVATIVES OF AMIDAS OR PHARMACEUTICALLY ACCEPTABLE SALTS OF THE SAME, PROCESSES OF PHARMACEUTICAL PREPARATIONS CONTAINING THEM AND APPLICATIONS
UY35209A (en) TRICYCLIC COMPOUNDS
UY30788A1 (en) CHEMICAL COMPOUNDS

Legal Events

Date Code Title Description
FA Abandonment or withdrawal